🔴 Biomea Fusion is trading 6% down today with biotech-sector weakness

Biomea Fusion is trading at $1.28, down 5.89%, as biotech shares face pressure, though no specific company news explaining the decline was found.

• The XBI is down 2.01% in the regular session, a possible contributing sector factor.
• Investors await Phase I results for oral obesity candidate BMF-650, scheduled for October 13, 2026, at 4:30 p.m. ET; the readout had not occurred by 10:30 a.m. ET.